The Risk of Cervical Cancer Doesn’t End with Menopause: Fortis Hospital Anandapur Emphasizes the Importance of Timely Screening  

The Risk of Cervical Cancer Doesn’t End with Menopause: Fortis Hospital Anandapur Emphasizes the Importance of Timely Screening  

 Kolkata, February 2025: Despite the common misconception that cervical cancer primarily affects younger women, medical experts stress the importance of awareness, screening, and prevention amongst  women approaching menopause. As women age, the risk of developing cervical cancer can still persist, and many may not realize that they remain vulnerable even after menopause. Regular Pap smears, HPV testing, and consultations with healthcare providers are crucial for early detection and prevention, ensuring that women of all ages are empowered to protect their health. A retrospective study conducted by a Healthcare Provider during October 2015 to September 2016), analyzed the PAP smear data  which revealed a higher prevalence of premalignant and malignant lesions among postmenopausal women compared to premenopausal women. 

 According to the National Cancer Registry Program of India, approximately 123,907 women are diagnosed with cervical cancer annually. This highlights the importance for better awareness and early detection efforts, particularly among older women who may not recognize their risk. 

 Sharing insights on the same Dr. Ashish Upadhyay, Consultant, Medical Oncology, Fortis Anandapur, Kolkata, says, “Cervical cancer can occur after menopause, and it’s critical for women to continue screening until the age of 65. Symptoms such as postmenopausal bleeding, postcoital bleeding, lower vaginal discharge, pelvic pain, and hematuria should prompt immediate medical consultation.” 

 While the risk of cervical cancer can increase due to factors like smoking, alcohol consumption, and sexual activity, Dr. Ashish adds, “It’s essential to understand that even beyond the age of 65, any abnormal symptoms should be assessed by a gynecologist to rule out cervical cancer or other conditions.” 

 In India, cervical cancer remains under-diagnosed, particularly among women over 40. Despite being a highly treatable cancer, many patients delay seeking medical help due to societal stigma and lack of  

 awareness. “Approximately 60-65% of cervical cancer patients in OPD consultations are over 40 years old, and sadly, a significant number are diagnosed at advanced stages,” says Dr. Ashish. 

 The introduction of the affordable HPV vaccine has opened new doors for prevention. Dr. Ashish further highlights, “HPV vaccination, especially for girls aged 9-26 years, can significantly reduce the incidence of cervical cancer. However, many women today, especially those above 40, were not vaccinated during their eligible years, contributing to a higher number of cases among older women.” 

 Despite the proven benefits of the HPV vaccination, awareness and uptake remain low in India. As part of global efforts to eliminate cervical cancer by 2030, the World Health Organization (WHO) introduced the 90-70-90 strategy. “The WHO’s strategy aims to vaccinate 90% of girls against HPV by the age of 15, screen 70% of women by the ages of 35 and 45, and ensure that 90% of diagnosed cases receive appropriate treatment,” explains Dr. Ashish. “By achieving these goals, we can significantly reduce cervical cancer as a global health burden.” 

 While HPV vaccination is crucial for younger women, Dr. Ashish emphasizes that for women over the age of 30-35, vaccination along with regular screening at specified intervals is equally important. 

 Dr. Ashish emphasizes that regular screening remains crucial for early detection: 

 Ages 20-30: Pap smear every three years 

• Ages 30-65: Co-testing (Pap smear + HPV test) every five years 

 Oncologists play a key role in raising awareness, with Dr. Ashish actively participating in educational efforts. “Each consultation is an opportunity to educate women and their families about the importance of HPV vaccination and early screening. We must make every effort to spread awareness and reduce the stigma surrounding cervical cancer.” 

 Cervical cancer treatment is highly effective, with options ranging from surgery for early-stage cancer to radiation and brachytherapy for more advanced stages. “Even in stage 4, some cases remain curable with prolonged treatment,” Dr. Ashish notes. 

 Dr. Ashish urges, “By promoting awareness, early detection through screening, and vaccination, we can significantly reduce the impact of cervical cancer in India. It is not just a fight against cancer; it is a fight for women’s health and well-being.”